Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, DraftKings, SVB, and Amgen and Encourages Investors to Contact the Firm
27 mars 2023 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, March 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, Amgen, and Signature and Encourages Investors to Contact the Firm
22 mars 2023 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
AMGEN INC. (NASDAQ: AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc. (NASDAQ: AMGN)
20 mars 2023 01h45 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Amgen Inc.? If so, please visit Amgen Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, Credit Suisse, SVB, and Amgen and Encourages Investors to Contact the Firm
17 mars 2023 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, March 17, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
DEADLINE ALERT for SIVB, AMGN, and SBNY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
17 mars 2023 12h00 HE
|
The Law Offices of Frank R. Cruz
LOS ANGELES, March 17, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
AMGEN INC. (NASDAQ: AMGN) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Amgen Inc. (NASDAQ: AMGN)
15 mars 2023 16h00 HE
|
Bernstein Liebhard LLP
Did you lose money on investments in Amgen Inc.? If so, please visit Amgen Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your...
Cell and Gene Therapy Market accounted for US$ 2.38 billion in 2020 and is projected to register CAGR of 35.50% - By PMI
16 janv. 2023 10h08 HE
|
PMI
Covina, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Cell therapy and gene therapy are fields of biomedical research and treatment, both therapies aim to treat, prevent, or potentially cure diseases, and both...
Revolution Medicines Doses First Patient in Phase 1/1b Clinical Trial of RMC-6291, Company’s First Mutant-Selective RAS(ON) Inhibitor
22 sept. 2022 07h00 HE
|
Revolution Medicines, Inc.
KRASG12C(ON) Inhibitor with highly differentiated mechanism of action being evaluated in patients with cancers harboring KRASG12C mutation RMC-6291 is first mutant-selective RAS(ON) Inhibitor to...
Arthritis Foundation President and CEO Steven Taylor Rides Out with 22nd Annual California Coast Classic Presented by Amgen
12 sept. 2022 09h00 HE
|
The Arthritis Foundation’s California Coast Classic Bicycle Tour
SAN FRANCISCO, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Arthritis Foundation President and Chief Executive Officer Steven Taylor joined riders of The California Coast Classic + Arthritis Challenge...
CHEMOCENTRYX, INC. ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of CCXI and Encourages Investors to Contact the Firm
07 août 2022 20h05 HE
|
Bragar Eagel & Squire
NEW YORK, Aug. 07, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors...